Results in cell and mouse studies may have implications for the development of a new class of anticancer drugs.
Scientists at the National Institutes of Health and Massachusetts General Hospital in Boston have uncovered a potential new approach against liver cancer that could lead to the development of a new class of anticancer drugs.… Read full story